NEW YORK (GenomeWeb News) – Bulldog Bio will distribute BioCellChallenge's entire line of molecular delivery reagents in the US under a deal announced today.
Products covered by the deal include BioCellChallenge's novel chemistries for DNA and SiRNA transfection experiments and reagents for transporting proteins directly into cells.
Financial and other terms were not disclosed.
BioCellChallenge's reagents "offer a completely new approach to introducing plasmid, siRNAs and proteins into the cytoplasm and nucleus of cells," Ella Fontaine, vice president of communications for Bulldog Bio, said in a statement. "We're particularly excited about the encouraging results seen with primary and stem cells."
Bulldog Bio distributes tools to life science researchers and is based in Portsmouth, NH. BioCellChallenge is headquartered in France and is a privately held biotechnology firm specializing in drug delivery systems.